Development of an External Control Arm Using Electronic Health Record-Based Real-World Data to Evaluate the Efficacy

Ji-Young Jeon1,2, Min-Ji Kim1,3, Yong-Jin Im1,2

  • 1Center for Clinical Pharmacology, Jeonbuk National University Hospital, Jeonju, Korea.

Insights

Building an external control arm (ECA) using real-world data (RWD) from COVID-19 patients showed no significant difference in recovery time compared to traditional randomized controlled trials (RCTs). This approach can accelerate new treatment development during pandemics.

Area of Science:

  • Clinical Trials
  • Real-World Evidence
  • Health Informatics

Background:

  • Developing treatments for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is crucial for public health.
  • Externally controlled trials (ECTs) offer a potential method to expedite drug development timelines.
  • Evaluating the feasibility of ECTs using real-world data (RWD) is essential for regulatory decision-making.

Purpose of the Study:

  • To assess the feasibility of using an external control arm (ECA) derived from RWD for coronavirus disease 19 (COVID-19) treatment trials.
  • To compare an ECA built from electronic health record (EHR) data against the control arm of a randomized controlled trial (RCT).

Main Methods:

  • An ECA was constructed using RWD from an EHR-based COVID-19 cohort.
  • The ECA served as the control for previously conducted Adaptive COVID-19 Treatment Trials (ACTT).
  • Propensity score matching was employed to balance covariates (age, sex, baseline clinical status) between the ECA and RCT control groups.

Main Results:

  • No statistically significant differences were observed in the time to recovery between the ECAs and the control arms of the ACTT trials.
  • The baseline clinical status ordinal score was the most influential covariate in constructing the ECA.
  • Propensity score matching successfully balanced key patient characteristics.

Conclusions:

  • External control arms built from EHR-derived RWD are a viable substitute for traditional RCT control arms in COVID-19 treatment studies.
  • This methodology can significantly accelerate the development of novel therapeutics, particularly during public health emergencies.
  • ECTs using RWD hold promise for more efficient drug development and regulatory review processes.

Related Concept Videos

Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
7.9K
Methods of Documentation VII: EMR01:30

Methods of Documentation VII: EMR

Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...
879
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
153
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
319
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K